SPPI
Closed
Spectrum Pharmaceuticals Inc
1.03
0.00 (0.00%)
Last Update: 04 Aug 2023 16:30:00
Yesterday: 1.03
Day's Range: 1.03 - 1.03
Send
sign up or login to leave a comment!
When Written:
0.6799
Spectrum Pharmaceuticals Inc. is a biopharmaceutical company that develops and commercializes oncology and hematology drug products. The company was founded in 1987 and is headquartered in Henderson, Nevada.
Spectrum's portfolio includes several FDA-approved drugs, including Fusilev (levoleucovorin), which is used to treat colorectal cancer, and Zevalin (ibritumomab tiuxetan), which is used to treat non-Hodgkin's lymphoma.
The company also has several drugs in development, including poziotinib, a potential treatment for non-small cell lung cancer, and Rolontis, a drug for the treatment of chemotherapy-induced neutropenia.
Spectrum Pharmaceuticals is publicly traded on the NASDAQ under the symbol "SPPI."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Spectrum's portfolio includes several FDA-approved drugs, including Fusilev (levoleucovorin), which is used to treat colorectal cancer, and Zevalin (ibritumomab tiuxetan), which is used to treat non-Hodgkin's lymphoma.
The company also has several drugs in development, including poziotinib, a potential treatment for non-small cell lung cancer, and Rolontis, a drug for the treatment of chemotherapy-induced neutropenia.
Spectrum Pharmaceuticals is publicly traded on the NASDAQ under the symbol "SPPI."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!